D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Qualcomm
QCOM
|
+$555M |
| 2 |
Marathon Petroleum
MPC
|
+$538M |
| 3 |
Ford
F
|
+$529M |
| 4 |
Walmart
WMT
|
+$508M |
| 5 |
Apple
AAPL
|
+$499M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$716M |
| 2 |
Merck
MRK
|
+$498M |
| 3 |
Meta Platforms (Facebook)
META
|
+$425M |
| 4 |
McDonald's
MCD
|
+$369M |
| 5 |
Wells Fargo
WFC
|
+$362M |
Sector Composition
| 1 | Technology | 20.88% |
| 2 | Consumer Discretionary | 13.12% |
| 3 | Healthcare | 9.93% |
| 4 | Communication Services | 9.58% |
| 5 | Financials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXPR
626
DELISTED
Express, Inc.
EXPR
| $19.7M | 0.02% |
152,102
+4,724
| +3% | +$613K |
|
627
Illinois Tool Works
ITW
$76.5B
| $19.7M | 0.02% |
88,296
+85,352
| +2,899% | +$19.1M |
|
628
Semtech
SMTC
$5.36B
| $19.7M | 0.02% |
285,967
+213,581
| +295% | +$14.7M |
|
629
Belden
BDC
$5.15B
| $19.6M | 0.02% |
388,528
-76,856
| -17% | -$3.89M |
|
630
EPR Properties
EPR
$4.19B
| $19.4M | 0.02% |
+368,782
| New | +$19.4M |
|
631
Inovio Pharmaceuticals
INO
$140M
| $19.4M | 0.02% |
174,155
+98,121
| +129% | +$10.9M |
|
632
Flowserve
FLS
$7.35B
| $19.3M | 0.02% |
479,087
-247,739
| -34% | -$9.99M |
|
633
FTI Consulting
FCN
$5.23B
| $19.3M | 0.02% |
141,339
-56,132
| -28% | -$7.67M |
|
634
Gen Digital
GEN
$18B
| $19.3M | 0.02% |
707,695
-287,519
| -29% | -$7.83M |
|
|
SJR
635
DELISTED
Shaw Communications Inc.
SJR
| $19.3M | 0.02% |
664,615
+558,766
| +528% | +$16.2M |
|
636
Tri Pointe Homes
TPH
$3.07B
| $19.2M | 0.02% |
894,736
+72,838
| +9% | +$1.56M |
|
637
Medical Properties Trust
MPW
$2.77B
| $19.1M | 0.02% |
951,894
+756,081
| +386% | +$15.2M |
|
|
MRTX
638
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $19M | 0.02% |
117,647
+35,725
| +44% | +$5.77M |
|
639
Impinj
PI
$5.53B
| $19M | 0.02% |
368,035
-114,569
| -24% | -$5.91M |
|
640
LKQ Corp
LKQ
$8.26B
| $19M | 0.02% |
385,742
+119,358
| +45% | +$5.87M |
|
641
Vanda Pharmaceuticals
VNDA
$265M
| $19M | 0.02% |
881,347
+126,918
| +17% | +$2.73M |
|
642
Pinnacle West Capital
PNW
$10.5B
| $19M | 0.02% |
231,205
-30,459
| -12% | -$2.5M |
|
643
CareTrust REIT
CTRE
$7.54B
| $18.9M | 0.02% |
813,082
-251,904
| -24% | -$5.85M |
|
644
Williams-Sonoma
WSM
$24.7B
| $18.8M | 0.02% |
235,860
+75,798
| +47% | +$6.05M |
|
645
Ventas
VTR
$31.5B
| $18.8M | 0.02% |
+328,561
| New | +$18.8M |
|
646
Health Care Select Sector SPDR Fund
XLV
$34B
| $18.7M | 0.02% |
+148,700
| New | +$18.7M |
|
647
Avanos Medical
AVNS
$558M
| $18.7M | 0.02% |
514,687
+320,127
| +165% | +$11.6M |
|
648
NiSource
NI
$19.2B
| $18.7M | 0.02% |
763,666
-647,411
| -46% | -$15.9M |
|
|
VRN
649
DELISTED
Veren
VRN
| $18.6M | 0.02% |
4,118,515
-1,907,600
| -32% | -$8.63M |
|
650
Intellia Therapeutics
NTLA
$1.21B
| $18.6M | 0.02% |
114,992
-288,728
| -72% | -$46.7M |
|